Evaluation of extrahepatic collateral arteries in hepatocellular carcinoma in three independent groups in a single center

Zhao,Yilin; Fang,Zhuting; Luo,Jianjun; Liu,Qingxin; Xu,Gang; Pan,Heng; Wei,Wei; Yan,Zhiping

doi:10.3892/etm.2015.2822

Evaluation of extrahepatic collateral arteries in hepatocellular carcinoma in three independent groups in a single center

Authors:
- Yilin Zhao
- Zhuting Fang
- Jianjun Luo
- Qingxin Liu
- Gang Xu
- Heng Pan
- Wei Wei
- Zhiping Yan
View Affiliations

Affiliations: Department of Oncological and Vascular Interventional Radiology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, P.R. China, Department of Interventional Radiology, Provincial Hospital of Fujian, Fuzhou, Fujian 350014, P.R. China, Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China
Published online on: October 22, 2015 https://doi.org/10.3892/etm.2015.2822
Pages: 2366-2374

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To improve the efficacy of transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), this study evaluated the prevalence and causes of extrahepatic arteries (EHAs) and identified feeding arteries in HCCs in three independent clinical groups in a single inverventional radiology center. Between November 2011 and September 2012, 942 cases of HCC were included in this retrospective study. The patients were treated in three independent groups of 285, 301 and 356 patients, respectively. Enhanced computed tomography, enhanced magnetic resonance imaging and digital subtraction angiography were reviewed retrospectively and correlations between the presence of tumor‑feeding EHAs and tumor number, size and location in the liver, number of repeat TACE procedures and complications were assessed. There were 698 EHAs in the 942 cases of HCC, with 182, 233 and 283 EHAs in the three independent groups, respectively. Tumor size was associated with EHA formation; the percentages of patients with EHAs were 2.7±3.0, 5.5±0.5, 43.2±4.0, 61.8±5.2 and 93.4±1.8% with tumor sizes of 2‑3, 3‑5, 5‑7, 7‑9 and >9 cm, respectively. There were 159±19 EHAs in each group feeding tumors in peripheral locations in the liver, but only 48.7±6.8 in the central zone. The most common EHA was the right inferior phrenic artery, with a mean of 101.0±14.1 per group. The number of EHAs increased proportionally with the number of TACE sessions. The number of EHAs was positively associated with tumor size, peripheral location of the tumor and number of TACE sessions.

View Figures

View References

1	Sergio A, Cristofori C, Cardin R, et al: Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): The role of angiogenesis and invasiveness. Am J Gastroenterol. 103:914–921. 2008. View Article : Google Scholar : PubMed/NCBI
2	Lee HS, Kim JS, Choi IJ, et al: The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer. 79:2087–2094. 1997. View Article : Google Scholar : PubMed/NCBI
3	Takayasu K, Arii S, Ikai I, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 131:461–469. 2006. View Article : Google Scholar : PubMed/NCBI
4	Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 148:397–401. 1983. View Article : Google Scholar : PubMed/NCBI
5	Yoon CJ, Chung JW, Park JH, et al: Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor. Radiology. 229:126–131. 2003. View Article : Google Scholar : PubMed/NCBI
6	Tsimberidou AM, Letourneau K, Fu S, et al: Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement. Cancer Chemother Pharmacol. 68:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
7	Kim HC, Chung JW, Lee W, Jae HJ and Park JH: Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics. 25(Suppl 1): S25–S39. 2005. View Article : Google Scholar : PubMed/NCBI
8	Miyayama S, Matsui O, Taki K, et al: Extrahepatic blood supply to hepatocellular carcinoma: Angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol. 29:39–48. 2006. View Article : Google Scholar : PubMed/NCBI
9	Park SI, Lee DY, Won JY and Lee JT: Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries. J Vasc Interv Radiol. 14:461–468. 2003. View Article : Google Scholar : PubMed/NCBI
10	Shibata T, Kojima N, Tabuchi T, Itoh K and Konishi J: Transcatheter arterial chemoembolization through collateral arteries for hepatocellular carcinoma after arterial occlusion. Radiat Med. 16:251–256. 1998.PubMed/NCBI
11	Chung JW, Kim HC, Yoon JH, et al: Transcatheter arterial chemoembolization of hepatocellular carcinoma: Prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol. 7:257–266. 2006. View Article : Google Scholar : PubMed/NCBI
12	Wang YL, Li MH, Cheng YS, Shi HB and Fan HL: Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma. World J Gastroenterol. 11:2637–2642. 2005. View Article : Google Scholar : PubMed/NCBI
13	Kim HC, Chung JW, Park JH, et al: Transcatheter arterial chemoembolization for hepatocellular carcinoma: Prospective assessment of the right inferior phrenic artery with C-arm CT. J Vasc Interv Radiol. 20:888–895. 2009. View Article : Google Scholar : PubMed/NCBI
14	Kim HC, Chung JW, Jae HJ, et al: Hepatocellular carcinoma: Prediction of blood supply from an internal mammary artery with multi-detector row CT. J Vasc Interv Radiol. 19:1419–1426. 2008. View Article : Google Scholar : PubMed/NCBI
15	Kim HC, Chung JW, Choi SH, et al: Internal mammary arteries supplying hepatocellular carcinoma: Vascular anatomy at digital subtraction angiography in 97 patients. Radiology. 242:925–932. 2007. View Article : Google Scholar : PubMed/NCBI
16	Kim HC, Chung JW, Jae HJ, et al: Hepatocellular carcinoma: Transcatheter arterial chemoembolization of the gonadal artery. J Vasc Interv Radiol. 17:703–709. 2006. View Article : Google Scholar : PubMed/NCBI
17	Peng ZW, Guo RP, Zhang YJ, et al: Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 118:4725–4736. 2012. View Article : Google Scholar : PubMed/NCBI
18	Xi T, Lai EC, Min AR, et al: Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: A non-randomized comparative study. Hepatogastroenterology. 59:1198–1203. 2012.PubMed/NCBI
19	Luo XJ, Tan WF, Yi B, et al: Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: Efficacy for criteria for different therapy modalities. Langenbecks Arch Surg. 394:1033–1039. 2009. View Article : Google Scholar : PubMed/NCBI
20	Wu Q and Qin SK: Features and treatment options of Chinese hepatocellular carcinoma. Chin Clin Oncol. 2:382013.PubMed/NCBI
21	Llovet JM, Fuster J and Bruix J: Barcelona-Clínic Liver Cancer Group: The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 10(2 Suppl 1): S115–S120. 2004. View Article : Google Scholar : PubMed/NCBI
22	Lencioni R, Chen XP, Dagher L and Venook AP: Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: How can outcomes be improved? Oncologist. 15(Suppl 4): 42–52. 2010. View Article : Google Scholar : PubMed/NCBI
23	Forner A, Reig ME, de Lope CR and Bruix J: Current strategy for staging and treatment: The BCLC update and future prospects. Semin Liver Dis. 30:61–74. 2010. View Article : Google Scholar : PubMed/NCBI
24	Welker MW, Zangos S, Kriener S, et al: Sequential therapy of transarterial chemoembolisation and sorafenib in intermediate stage hepatocellular carcinoma. J Gastrointest Cancer. 41:149–152. 2010. View Article : Google Scholar : PubMed/NCBI
25	Miyayama S, Yamashiro M, Okuda M, et al: The march of extrahepatic collaterals: Analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization. Cardiovasc Intervent Radiol. 33:513–522. 2010. View Article : Google Scholar : PubMed/NCBI
26	Won JY, Lee DY, Lee JT, et al: Supplemental transcatheter arterial chemoembolization through a collateral omental artery: Treatment for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 26:136–140. 2003. View Article : Google Scholar : PubMed/NCBI
27	Kimura S, Okazaki M, Higashihara H, et al: Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization. Hepatogastroenterology. 56:191–198. 2009.PubMed/NCBI
28	Vaidya S, Dighe M, Bhargava P and Dick AA: Chronic hepatic artery occlusion with collateral formation: Imaging findings and outcomes. Transplant Proc. 43:1770–1776. 2011. View Article : Google Scholar : PubMed/NCBI
29	Yang L, Zhang XM, Ren YJ, Miao ND, Huang XH and Dong GL: The features of extrahepatic collateral arteries related to hepatic artery occlusion and benefits in the transarterial management of liver tumors. Radiol Res Prac. 2013:5352722013.
30	Miyayama S, Yamashiro M, Yoshie Y, et al: Inferior phrenic arteries: Angiographic anatomy, variations and catheterization techniques for transcatheter arterial chemoembolization. Jpn J Radiol. 28:502–511. 2010. View Article : Google Scholar : PubMed/NCBI
31	Guan YS, Zheng XH, Zhou XP, et al: Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Gastroenterol. 10:2127–2129. 2004. View Article : Google Scholar : PubMed/NCBI
32	Kodama Y, Shimizu T, Endo H, et al: Spontaneous rupture of hepatocellular carcinoma supplied by the right renal capsular artery treated by transcatheter arterial embolization. Cardiovasc Intervent Radiol. 25:137–140. 2002. View Article : Google Scholar : PubMed/NCBI
33	Eurvilaichit C: Outcome of transcatheter oily chemoembolization in patients with hepatocellular carcinoma. Hepatogastroenterology. 51:20–24. 2004.PubMed/NCBI
34	Paul SB, Gamanagatti SR, Mukund A, Abbas SZ and Acharya SK: Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply. Indian J Cancer. 48:339–344. 2011. View Article : Google Scholar : PubMed/NCBI
35	Hu ML, Tai WC, Chuah SK, et al: Gastric metastasis of hepatocellular carcinoma via a possible existing retrograde hematogenous pathway. J Gastroenterol Hepatol. 25:408–412. 2010. View Article : Google Scholar : PubMed/NCBI
36	Zech CJ, Bilzer M, Mueller-Lisse UG, et al: Perforation of the colon: A rare complication of hepatocellular carcinoma. Acta Radiol. 47:538–542. 2006. View Article : Google Scholar : PubMed/NCBI
37	Uchino K, Tateishi R, Shiina S, et al: Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors. Cancer. 117:4475–4483. 2011. View Article : Google Scholar : PubMed/NCBI
38	Choi JW, Kim HC, Chung JW, et al: Chemoembolization via branches from the splenic artery in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol. 35:90–96. 2012. View Article : Google Scholar : PubMed/NCBI
39	Baba Y, Miyazono N, Inoue H, et al: Small hepatocellular carcinoma supplied by the right renal capsular artery. A case report. Acta Radiol. 40:449–450. 1999. View Article : Google Scholar : PubMed/NCBI
40	Jeon UB, Lee JW, Baik SK, et al: Hepatocellular carcinoma supplied from the short gastric artery: Treatment with chemoembolization. Cardiovasc Intervent Radiol. 35:1512–1514. 2012. View Article : Google Scholar : PubMed/NCBI
41	Miyayama S, Yamashiro M, Okuda M, et al: Hepatocellular carcinoma supplied by the right lumbar artery. Cardiovasc Intervent Radiol. 33:53–60. 2010. View Article : Google Scholar : PubMed/NCBI
42	Shin SW, Do YS, Choo SW, et al: Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinoma. Radiology. 241:581–588. 2006. View Article : Google Scholar : PubMed/NCBI
43	Nakamura H, Hashimoto T, Oi H, Sawada S and Furui S: Prevention of gastric complications in hepatic arterial chemoembolization. Balloon catheter occlusion technique. Acta Radiol. 32:81–82. 1991. View Article : Google Scholar : PubMed/NCBI
44	Shah RP and Brown KT: Hepatic arterial embolization complicated by acute cholecystitis. Semin Intervent Radiol. 28:252–257. 2011. View Article : Google Scholar : PubMed/NCBI
45	Jeon SH, Park KS, Kim YH, et al: Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma. Korean J Gastroenterol. 50:176–182. 2007.(In Korean). PubMed/NCBI
46	Sueyoshi E, Hayashida T, Sakamoto I and Uetani M: Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol. 195:245–251. 2010. View Article : Google Scholar : PubMed/NCBI
47	Negrini S, Zoppoli G, Andorno E, Picciotto A and Indiveri F: Iodized oil pleural effusion in a patient previously treated with transarterial chemoembolization for hepatocellular carcinoma. Chest. 138:193–195. 2010. View Article : Google Scholar : PubMed/NCBI
48	Naorungroj T, Naksanguan T and Chinthammitr Y: Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review. J Med Assoc Thai. 96(Suppl 2): 270–275. 2013.
49	Poggi G, Pozzi E, Riccardi A, et al: Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. Anticancer Res. 30:5159–5164. 2010.PubMed/NCBI